ArticleBrain : a journal of neurology2020
Long duration response in Parkinson's disease: levodopa revisited.
Article in Brain : a journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Effects of Wearable Devices on Parkinson Disease: Systematic Review and Meta-Analysis of Randomized Controlled Trials Within the International Classification of Functioning, Disability, and Health Framework.Journal of medical Internet research · 2026Pooled it
- Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson's disease: a systematic review and meta-analysis.Journal of neurology · 2025Pooled it
- Long-Duration Response to Levodopa in the PPMI-Cohort.Movement disorders : official journal of the Movement Disorder Society · 2026Article
- Moving beyond monitoring: wearable technology (PKG) for the diagnosis of Parkinson's disease.BMJ neurology open · 2026Article
- Modulatory effect of levodopa on the basal ganglia-cerebellum connectivity in Parkinson's disease.NPJ Parkinson's disease · 2025Article
- Inhaled levodopa for threatening impending OFF episodes in managing Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2023Review
- Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease.Movement disorders clinical practice · 2023Article
- Evaluation of the PREDIGT score's performance in identifying newly diagnosed Parkinson's patients without motor examination.NPJ Parkinson's disease · 2022Article
- Comparative efficacy of surgical approaches to disease modification in Parkinson disease.NPJ Parkinson's disease · 2022Review
- Should "on-demand" treatments for Parkinson's disease OFF episodes be used earlier?Clinical parkinsonism & related disorders · 2022Review
- A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.Frontiers in neurology · 2021Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32844192What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.